Covington Capital Management’s Abiomed Inc ABMD Stock Holding History

Covington Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1K	Buy	+6	New	+$1.62K	﹤0.01%	1181
2020 Q4	–	Sell	-15	Closed	-$4K	–	816
2020 Q3	$4K	Hold	15	–	–	﹤0.01%	720
2020 Q2	$4K	Hold	15	–	–	﹤0.01%	709
2020 Q1	$2K	Hold	15	–	–	﹤0.01%	730
2019 Q4	$3K	Hold	15	–	–	﹤0.01%	845
2019 Q3	$3K	Hold	15	–	–	﹤0.01%	766
2019 Q2	$4K	Hold	15	–	–	﹤0.01%	736
2019 Q1	$4K	Hold	15	–	–	﹤0.01%	689
2018 Q4	$5K	Hold	15	–	–	﹤0.01%	692
2018 Q3	$7K	Buy	+15	New	+$5.91K	﹤0.01%	634

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Covington Capital Management's ABMD Position: Q3 2022 in Review

Covington Capital Management opened a new position in Abiomed Inc (ABMD) in Q3 2022: 6 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1181 among its holdings. This is a return to the name: Covington Capital Management previously reported a position in ABMD as recently as Q3 2020.

Covington Capital Management first reported a position in ABMD in Q3 2018 and has held it in 10 quarters since. The position peaked at $7K in Q3 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

Covington Capital Management held 6 shares of Abiomed Inc worth $1K as of Q3 2022.
Abiomed Inc was a new Covington Capital Management position in Q3 2022.
Abiomed Inc made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #1181 holding.
Covington Capital Management first reported a position in Abiomed Inc in Q3 2018 and has held it in 10 quarters since.
Covington Capital Management's Abiomed Inc position peaked at $7K in Q3 2018.
517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.